Who is sponsoring NCT05885360?

NCT05885360 is sponsored by Georgetown University.

What condition does NCT05885360 study?

NCT05885360 studies Parkinson Disease, Tremor.

What drugs are being tested in NCT05885360?

Interventions: Istradefylline Pill.

What is the status of NCT05885360?

NCT05885360 is currently COMPLETED.

Last reviewed 2025-03-13 · How we verify

Istradefylline Effect Protocol on Parkinson's Disease Tremor

NCT05885360 PHASE4 COMPLETED

This is an investigator-initiated trial. In this 6-month open label, single arm, exploratory pilot study, the investigator intends to enroll a pilot sample of 25 patients with Parkinson's disease who are being started on the novel FDA approved medication "Istradefylline'' as an add on therapy for management of their motor symptoms (based on the judgment of the movement disorders specialist, if patients are in sub-optimal management of their symptoms on maximum tolerable dose of their dopaminergic medications). The investigator will evaluate their motor symptoms before starting the new medication, including their MDS-UPDRS total and MDS-UPDRS-III scores.

Details

Lead sponsor	Georgetown University
Phase	PHASE4
Status	COMPLETED
Enrolment	27
Start date	Fri Jan 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Feb 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Parkinson Disease
Tremor

Interventions

Istradefylline Pill

Countries

United States